The anti-inflammatory non-antibiotic helper compound diclofenac: An antibacterial drug target

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 8, 2009, Pages 881-891

  Mazumdar, K ^a   Dastidar, S G ^b   Park, J H ^c   Dutta, N K ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b JADAVPUR UNIVERSITY   (India)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; GENTAMICIN; PHENOTHIAZINE; STREPTOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BACTERICIDAL ACTIVITY; DNA SYNTHESIS INHIBITION; DOSE RESPONSE; DRUG CLEARANCE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG SENSITIVITY; DRUG STRUCTURE; ESCHERICHIA COLI; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTERIAL INFECTIONS; DICLOFENAC; DISEASE MODELS, ANIMAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICE;

EID: 68849087196     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0739-z     Document Type: Review

References (78)

1. A Ray LB Rice 2004 Wildcatters welcome: the need for new antimicrobial agents Therapy 1 1 5 10.2217/14750708.1.1.1
2. I Chopra L Hesse AJ O'Neill 2002 Exploiting current understanding of antibiotic action for discovery of new drugs J Appl Microbiol 92 4S 15S 10.1046/j.1365-2672.92.5s1.13.x
3. R Finch 2002 Bacterial resistance-the clinical challenge Clin Microbiol Infect 8 Suppl 3 21 32 10.1046/j.1469-0691.8.s.3.3.x
4. C Walsh 2003 Where will new antibiotics come from? Nat Rev Microbiol 1 65 70 10.1038/nrmicro727
5. YY Chan YM Ong KL Chua 2007 Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei Antimicrob Agents Chemother 51 623 630 10.1128/AAC.01033-06 (Pubitemid 46185282)
6. JE Kristiansen O Hendricks T Delvin TS Butterworth L Aagaard JB Christensen VC Flores H Keyzer 2007 Reversal of resistance in microorganisms by help of non-antibiotics J Antimicrob Chemother 59 1271 1279 10.1093/jac/dkm071 (Pubitemid 47073346)
7. J Molnár 2006 The reversal of drug resistance from bacteria to cancer cells Curr Drug Targets 7 7 789 791 10.2174/138945006777709584
8. M Viveiros A Jesus M Brito C Leandro M Martins D Ordway AM Molnár J Molnár L Amaral 2005 Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes Antimicrob Agents Chemother 49 8 3578 3582 10.1128/AAC.49.8.3578-3582.2005 (Pubitemid 41060625)
9. GW Kaatz VV Moudgal SM Seo JE Kristiansen 2003 Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus Antimicrob Agents Chemother 47 2 719 726 10.1128/AAC.47.2.719-726.2003 (Pubitemid 36158106)
10. JE Kristiansen 1991 Antimicrobial activity of nonantibiotics Am Soc Microbiol News 57 3 135 139
11. JE Kristiansen L Amaral 1997 The potential management of resistant infections with non-antibiotics J Antimicrob Chemother 40 319 327 10.1093/jac/40.3.319 (Pubitemid 27437949)
12. L Amaral V Lorian 1991 Effects of chlorpromazine on the cell envelope proteins of Escherichia coli Antimicrob Agents Chemother 35 9 1923 1924
13. M Viveiros L Amaral 2001 Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines Int J Antimicrob Agents 17 3 225 228 10.1016/S0924-8579(00) 00343-5
14. NK Dutta S Annadurai K Mazumdar SG Dastidar JE Kristiansen J Molnár M Martins L Amaral 2007 Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium Int J Antimicrob Agents 30 3 242 249 10.1016/j.ijantimicag. 2007.04.018 (Pubitemid 47161124)
15. L Amaral M Martins M Viveiros 2007 Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps J Antimicrob Chemother 59 1237 1246
16. L Amaral M Martins M Viveiros 2008 Enhanced killing of intracellular pathogenic bacteria by phenothiazines and the role of K+ efflux pumps of the bacterium and the killing macrophage Anti-Infective Agents Med Chem 7 1 63 72 10.2174/187152108783329807
17. SG Dastidar PK Saha B Sanyamat AN Chakrabarty 1976 Antibacterial activity of ambodryl and benadryl J Appl Bacteriol 41 209 214
18. D Chattopadhyay SG Dastidar AN Chakrabarty 1998 Antimicrobial properties of methdilazine and its synergism with antibiotics and some chemotherapeutic agents Arzneimittelforschung 38 869 872
19. AN Chakrabarty DP Acharya DK Neogi SG Dastidar 1989 Drug interaction of promethazine & other non-conventional antimicrobial chemotherapeutic agents Indian J Med Res 89 233 237
20. SG Dastidar J Jairaj M Mookerjee AN Chakrabarty 1997 Studies on antimicrobial effect of the antihistaminic phenothiazine trimeprazine tartrate Acta Microbiol Immunol Hung 44 241 247
21. SK Dash SG Dastidar AN Chakrabarty 1977 Antimicrobial activity of promazine hydrochloride Indian J Exp Biol 15 324 326
22. SG Dastidar U Mondal S Niyogi AN Chakrabarty 1986 Antibacterial property of methyl-DOPA and development of cross-resistance in m-DOPA mutants Indian J Med Res 84 142 147
23. NK Dutta K Mazumdar SG Dastidar AN Chakrabarty Y Shirataki N Motohashi 2005 In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA In Vivo 19 539 545
24. A Sarkar KA Kumar NK Dutta P Chakraborty SG Dastidar 2003 Evaluation of in vitro and in vivo antibacterial activity of dobutamine hydrochloride Indian J Med Microbiol 21 3 172 178
25. KA Kumar K Ganguly K Mazumdar NK Dutta SG Dastidar AN Chakrabarty 2003 Amlodipine: a cardiovascular drug with powerful antimicrobial property Acta Microbiol Pol 52 3 285 292
26. K Mazumdar K Ganguly KA Kumar NK Dutta AN Chakrabarty SG Dastidar 2003 Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride Microbiol Res 158 259 264 10.1078/0944-5013-00204 (Pubitemid 37105754)
27. Manna KK, Dastidar SG (1984) The anti-hypertensive drug propranolol hydrochloride (carditap): its anti-bacterial property. In: Proceedings of the 6th National Congress of the Indian Association of Medical Microbiologists (IAMM), pp 137-141
28. P Karak KA Kumar K Mazumdar M Mookerjee SG Dastidar 2003 Antibacterial potential of an antispasmodic drug dicyclomine hydrochloride Indian J Med Res 118 192 196
29. P Karaka KA Kumar LR Basu A Dasgupta R Ray SG Dastidar 2004 Experimental analysis of antimicrobial action of dicyclomine hydrochloride Biol Pharm Bull 27 12 2010 2013 10.1248/bpb.27.2010 (Pubitemid 41701580)
30. SG Dastidar A Chaudhury S Annadurai S Roy M Mookerjee AN Chakrabarty 1995 In vitro and in vivo antimicrobial action of fluphenazine J Chemother 7 201 206
31. V Radhakrishnan K Ganguly M Ganguly SG Dastidar N Chakrabarty 1999 Potentiality of tricyclic compound thioridazine as an effective antibacterial and antiplasmid agent Indian J Exp Biol 37 671 675
32. P Bourlioux JM Moreaux WJ Su H Boureau 1992 In vitro antimicrobial activity of 18 phenothiazine derivatives: structure-activity relationship APMIS Suppl 30 40 43
33. M Martins Z Schelz A Martins J Molnár G Hajös Z Riedl M Viveiros I Yalcin E Aki-Sener L Amaral 2007 In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis Int J Antimicrob Agents 29 338 340 10.1016/j.ijantimicag.2006.10.013 (Pubitemid 46251471)
34. M Martins M Viveiros JE Kristiansen J Molnár L Amaral 2007 The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis In Vivo 21 5 771 775
35. S Annadurai S Basu S Ray SG Dastidar AN Chakrabarty 1998 Antibacterial activity of the antiinflammatory agent diclofenac sodium Indian J Exp Biol 36 86 90
36. NK Dutta K Mazumdar MW Baek DJ Kim YR Na SH Park HK Lee BH Lee JH Park 2008 In vitro efficacy of diclofenac against Listeria monocytogenes Eur J Clin Microbiol Infect Dis 27 4 315 319 10.1007/s10096-007-0439-5
37. NK Dutta K Mazumdar SH Seok JH Park 2008 The anti-inflammatory drug Diclofenac retains anti-listerial activity in vivo Lett Appl Microbiol 47 106 111 10.1111/j.1472-765X.2008.02391.x
38. AB Bender JE Kristiansen 1999 Antimicrobial effects of anesthetics and analgesics Ugeskr Laeger 161 42 5814 5817
39. WH Wang WM Wong D Dailidiene DE Berg Q Gu KC Lai SK Lam BC Wong 2003 Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents Gut 52 490 495 10.1136/gut.52.4.490 (Pubitemid 36363398)
40. AJ Crowle GS Douvas MH May 1992 Chlorpromazine: a drug potentially useful for treating mycobacterial infections Chemotherapy 38 410 419
41. M Wainwright L Amaral 2005 The phenothiazinium chromophore and the evolution of antimalarial drugs Trop Med Int Health 10 501 511 10.1111/j.1365-3156.2005.01417.x (Pubitemid 40806655)
42. D Chattopadhyay SG Dastidar AN Chakrabarty 1987 Determination of in vitro activity of methdilazine, an antihistamine, and its synergism with aminoglycoside antibiotics Indian J Med Microbiol 5 171 177
43. S Ray D Chattopadhyay SG Dastidar AN Chakrabarty 1990 Studies on synergism between penicillins and ambodryl (bromodiphenhydramine HCl), an antihistamine with antimicrobial property Indian J Exp Biol 28 253 258
44. SG Dastidar P Chakraborty M Mookerjee M Ganguly AN Chakrabarty 1994 Studies on the existence of synergism between different antibiotics and a phenothiazine tranquilizer, promazine, possessing antimicrobial property Acta Microbiol Immunol Hung 41 1 41 49
45. G Gunics N Motohashi L Amaral S Farkas J Molnár 2000 Interaction between antibiotics and non-conventional antibiotics on bacteria Int J Antimicrob Agents 14 3 239 242 10.1016/S0924-8579(00) 00131-X
46. J Molnár I Haszon T Bodrogi E Martonyi S Turi 1990 Synergistic effect of promethazine with gentamycin in frequently recurring pyelonephritis Int J Urol Nephrol 22 5 405 411 10.1007/BF02549770
47. L Amaral JE Kristiansen V Lorian 1992 Synergic effect of chlorpromazine on the activity of some antibiotics J Antimicrob Chemother 30 556 558 10.1093/jac/30.4.556
48. M Viveiros L Amaral 2001 Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines Int J Antimicrob Agents 17 225 228 10.1016/S0924-8579(00) 00343-5
49. NK Dutta K Mazumdar SG Dastidar JH Park 2007 Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice Int J Antimicrob Agents 30 4 336 340 10.1016/j.ijantimicag.2007.04.016 (Pubitemid 47371086)
50. KA Kumar K Mazumdar NK Dutta P Karak SG Dastidar R Ray 2004 Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipine Biol Pharm Bull 27 7 1116 1120 10.1248/bpb.27.1116 (Pubitemid 41701770)
51. K Mazumdar NK Dutta KA Kumar SG Dastidar 2005 In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains Biol Pharm Bull 28 4 713 717 10.1248/bpb.28.713 (Pubitemid 40879943)
52. AN Chakrabarty M Mookerjee SG Dastidar 2000 Screening for anti-HIV drugs that can combine virucidal and virustatic activities synergistically Int J Antimicrob Agents 14 215 220 10.1016/S0924-8579(99) 00158-2
53. A Guha Thakurta SK Mandal K Ganguly SG Dastidar AN Chakrabarty 2000 A new powerful antibacterial synergistic combination of trimethoprim and trimeprazine Acta Microbiol Immunol Hung 47 21 28
54. L Rani Basu K Mazumdar NK Dutta P Karak SG Dastidar 2005 Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine Microbiol Res 160 95 100 10.1016/j.micres.2004.10.002 (Pubitemid 40199408)
55. L Amaral JE Kristiansen M Viveiros J Atouguia 2001 Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy J Antimicrob Chemother 47 505 511 10.1093/jac/47.5.505
56. L Amaral JE Kristiansen 2000 Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies Int J Antimicrob Agents 14 173 176 10.1016/S0924-8579(99) 00153-3
57. K Mazumdar NK Dutta SG Dastidar N Motohashi Y Shirataki 2006 Diclofenac in the management of E. coli urinary tract infections In Vivo 20 5 613 619
58. NK Dutta KA Kumar K Mazumdar SG Dastidar 2004 In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium Indian J Exp Biol 42 922 927 (Pubitemid 39182852)
59. NK Dutta SG Dastidar A Kumar K Mazumdar R Ray AN Chakrabarty 2004 Antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin Braz J Microbiol 35 316 323 10.1590/S1517- 83822004000300009 (Pubitemid 41350722)
60. SG Dastidar K Ganguly K Chaudhuri AN Chakrabarty 2000 The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis Int J Antimicrob Agents 14 249 251 10.1016/S0924-8579(99) 00159-4
61. A Theodorou MA Demertzis D Kovala-Demertzi EE Lioliou AA Pantazaki DA Kyriakidis 1999 Copper(II) complexes of diclofenac: spectroscopic studies and DNA strand breakage BioMetals 12 2 167 172 10.1023/A:1009246122577 (Pubitemid 29276798)
62. P Ratnakar PS Murthy 1993 Trifluoperazine inhibits the incorporation of labelled precursors into lipids, proteins and DNA of Mycobacterium tuberculosis H37Rv FEMS Microbiol Lett 110 3 291 294 10.1111/j.1574-6968.1993.tb06337.x
63. JH Park YH Park SH Seok SA Cho DJ Kim HY Lee SH Kim JH Park 2004 Suppurative gastritis in BALB/c mice infected with Listeria monocytogenes via the intragastric route J Comp Pathol 130 130 136 10.1016/j.jcpa.2003.10.001 (Pubitemid 38279329)
64. JH Park DJ Kim YH Park SH Seok SA Cho MW Baek HY Lee JH Park 2004 Characteristics of the gastritis induced by Listeria monocytogenes in mice: microbiology, histopathology, and mRNA expression of inflammatory mediators with time course of infection Microb Pathog 37 87 94 10.1016/j.micpath.2004.05.002 (Pubitemid 39093880)
65. HY Lee JH Park SH Seok MW Baek DJ Kim BH Lee PD Kang YS Kim JH Park 2005 Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice J Med Microbiol 54 1049 1054 10.1099/jmm.0.45918-0 (Pubitemid 41566775)
66. G Ravel M Christ F Horand J Descotes 2004 Cytokine release does not improve the sensitivity and specificity of the direct popliteal lymph node assay Toxicology 200 247 254 10.1016/j.tox.2004.03.010 (Pubitemid 38798434)
67. C Sano T Shimizu K Sato H Kawauchi S Kawahara H Tomioka 1999 Therapeutic effects of benzoxazinorifamycin krm-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection in mice Antimicrob Agents Chemother 43 360 364
68. I Tsuboi H Tanaka M Nakao S Shichijo K Itoh 1995 Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production Cytokine 7 372 379 10.1006/cyto.1995.0047
69. Lewis AJ, Furst DW (1987) Nonsteroidal anti-inflammatory drugs: mechanisms and clinical use. Marcel Dekker, New York
70. D Sriram P Yogeeswari RV Devakaram 2006 Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides Bioorg Med Chem 14 3113 3118 10.1016/j.bmc.2005.12.042
71. Goodman GA (2001) NSAIDs. In: Hardman JH, Limbird LE, Goodman GA (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edn.. Vols I and II. McGraw-Hill, New York, pp 687-731
72. WF Shepherd MG Fsadni PS Raj 1998 A clinical evaluation of diclofenac-gentamicin combination eye drops in the control of inflammation after cataract surgery. Diclofenac-Gentamicin versus Gentamicin Study Group Ocul Immunol Inflamm 6 1 13 18 10.1076/ocii.6.1.13.8083 (Pubitemid 28254236)
73. DC Brater 1986 Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs Am J Med 80 Suppl 1A 62 77
74. M Kawase N Motohashi 2003 New multidrug resistance reversal agents Curr Drug Targets 4 1 31 43 10.2174/1389450033347064 (Pubitemid 36131639)
75. J Molnár S Földeák MJ Nakamura H Rausch K Domonkos M Szabó 1992 Antiplasmid activity: loss of bacterial resistance to antibiotics APMIS Suppl 30 24 31
76. N Motohashi M Kawase S Saito C Miskolci L Berek J Molnár 1999 Plasmid elimination and immunomodulation by 3-benzazepines in vitro Anticancer Res 19 6B 5075 5078
77. M Martins SG Dastidar S Fanning JE Kristiansen J Molnár JM Pagès Z Schelz G Spengler M Viveiros L Amaral 2008 Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities Int J Antimicrob Agents 31 198 208 10.1016/j.ijantimicag.2007.10.025
78. Dutta NK, Mazumdar K, Park JH (2009) In vitro synergistic effect of gentamicin with the anti-inflammatory agent diclofenac against Listeria monocytogenes. Lett Appl Microbiol. doi: 10.1111/j.1472-765X.2009.02588.x